Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Neosoma Brain Mets

K-Number: K252922 · 2025-12-17

ApplicantNeosoma, Inc.
Decision Date2025-12-17
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Neosoma Brain Mets is a medical device manufactured by Neosoma, Inc.. It received FDA 510(k) clearance on 2025-12-17 under approval number K252922. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Neosoma Brain Mets?

Neosoma Brain Mets is a medical device that received FDA 510(k) clearance on 2025-12-17. It is manufactured by Neosoma, Inc.. The 510(k) number is K252922.

When was Neosoma Brain Mets approved by the FDA?

Neosoma Brain Mets received FDA 510(k) clearance on 2025-12-17, under approval number K252922.

What company makes Neosoma Brain Mets?

Neosoma Brain Mets is manufactured by Neosoma, Inc..

What is the FDA product code for Neosoma Brain Mets?

The FDA product code for Neosoma Brain Mets is QIH.

Other Devices by Neosoma, Inc.

K221738NS-HGlio

Related Devices (Code: QIH)

K191647QLAB Advanced Quantification SoftwarePhilips Health Care K191171EchoGo CoreUltromics, Ltd. K201195syngo.via MI Workflows, syngo MBFSiemens Medical Solutions USA, Inc. K202013WRDensity by Whiterabbit.aiWhiterabbit.Ai, Inc. K202546LVivo SeamlessDia Imaging Analysis, Ltd. K193283AI-Rad Companion Prostate MRSiemens Medical Solutions USA, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑